Literature DB >> 15919780

Adenomyosis in endometriosis--prevalence and impact on fertility. Evidence from magnetic resonance imaging.

G Kunz1, D Beil, P Huppert, M Noe, S Kissler, G Leyendecker.   

Abstract

BACKGROUND: The hypothesis is tested that there is a strong association between endometriosis and adenomyosis and that adenomyosis plays a role in causing infertility in women with endometriosis. METHODS. Magnetic resonance imaging of the uteri was performed in 160 women with and 67 women without endometriosis. The findings were correlated with the stage of the disease, the age of the women and the sperm count parameters of the respective partners.
RESULTS: The posterior junctional zone (PJZ) was significantly thicker in women with endometriosis than in those without the disease (P<0.001). There was a positive correlation of the diameter of the PJZ with the stage of the disease and the age of the patients. The PJZ was thicker in patients with endometriosis with fertile than in patients with subfertile partners. The prevalence of adenomyotic lesions in all 160 women with endometriosis was 79%. In women with endometriosis below an age of 36 years and fertile partners, the prevalence of adenomyosis was 90% (P<0.01)
CONCLUSIONS: With a prevalence of up to 90%, uterine adenomyosis is significantly associated with pelvic endometriosis and constitutes an important factor of sterility in endometriosis presumably by impairing uterine sperm transport.

Entities:  

Mesh:

Year:  2005        PMID: 15919780     DOI: 10.1093/humrep/dei021

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  54 in total

1.  MRI, US or real-time virtual sonography in the evaluation of adenomyosis?

Authors:  Valeria Vinci; Matteo Saldari; Maria Eleonora Sergi; Silvia Bernardo; Giuseppe Rizzo; Maria Grazia Porpora; Carlo Catalano; Lucia Manganaro
Journal:  Radiol Med       Date:  2017-02-15       Impact factor: 3.469

Review 2.  Magnetic resonance imaging of acquired disorders of the pediatric female pelvis other than neoplasm.

Authors:  Mougnyan Cox; Sharon W Gould; Daniel J Podberesky; Monica Epelman
Journal:  Pediatr Radiol       Date:  2016-05-26

3.  Adenomyosis: Mechanisms and Pathogenesis.

Authors:  Junyu Zhai; Silvia Vannuccini; Felice Petraglia; Linda C Giudice
Journal:  Semin Reprod Med       Date:  2020-10-08       Impact factor: 1.303

4.  Global Transcriptome Abnormalities of the Eutopic Endometrium From Women With Adenomyosis.

Authors:  Christopher N Herndon; Lusine Aghajanova; Shaina Balayan; David Erikson; Fatima Barragan; Gabriel Goldfien; Kim Chi Vo; Shannon Hawkins; Linda C Giudice
Journal:  Reprod Sci       Date:  2016-05-27       Impact factor: 3.060

5.  Management of adenomyosis in subfertile women and pregnancy outcome.

Authors:  Fathia E Al Jama
Journal:  Oman Med J       Date:  2011-05

6.  Characteristics indicating adenomyosis coexisting with leiomyomas: a case-control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Hum Reprod       Date:  2010-02-22       Impact factor: 6.918

7.  Neurotrophin expression is not affected in uteri of women with adenomyosis.

Authors:  Maria Luisa Barcena de Arellano; Melanie Franziska Wagner; Jeannette Oldeweme; Julia Arnold; Andreas Ebert; Achim Schneider; Sylvia Mechsner
Journal:  J Mol Neurosci       Date:  2012-03-28       Impact factor: 3.444

8.  Understanding adenomyosis: a case control study.

Authors:  F Andrei Taran; Amy L Weaver; Charles C Coddington; Elizabeth A Stewart
Journal:  Fertil Steril       Date:  2009-07-30       Impact factor: 7.329

9.  Adenomyosis a variant, not a disease? Evidence from hysterectomized menopausal women in the Study of Women's Health Across the Nation (SWAN).

Authors:  Gerson Weiss; Priya Maseelall; Laura L Schott; Sarah E Brockwell; Miriam Schocken; Janet M Johnston
Journal:  Fertil Steril       Date:  2008-02-20       Impact factor: 7.329

10.  The pathophysiology of endometriosis and adenomyosis: tissue injury and repair.

Authors:  G Leyendecker; L Wildt; G Mall
Journal:  Arch Gynecol Obstet       Date:  2009-07-31       Impact factor: 2.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.